Antipruritic effect of prophylactic pentazocine combined with ultra-low-dose naloxone on intrathecal opioids-induced pruritus after cesarean delivery: a double-center prospective, controlled trial
Not Applicable
- Conditions
- Opioids-induced pruritus
- Registration Number
- JPRN-UMIN000027226
- Lead Sponsor
- Department of Anesthesiology, Shimane University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 101
Inclusion Criteria
Not provided
Exclusion Criteria
1) Emergency cesarean delivery 2) Allergy to pentazocine, naloxone, morphine, fentanyl, bupivacaine, or levobupivacaine 3) Preexisting pruritus 4)Patient with preeclampsia,diabetes mellitus; or neurologic disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the incidence of opioid-induced pruritus within the first 24 hr after administration of opioids.
- Secondary Outcome Measures
Name Time Method